⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

NIACL - Fundamental Analysis: Financial Health & Valuation

Back to List

Rating: 3.4

Last Updated Time : 04 May 26, 11:42 am

Fundamental Rating: 3.4

Stock Code NIACL Market Cap 26,467 Cr. Current Price 161 ₹ High / Low 215 ₹
Stock P/E 22.6 Book Value 169 ₹ Dividend Yield 1.12 % ROCE 3.72 %
ROE 3.54 % Face Value 5.00 ₹ DMA 50 150 ₹ DMA 200 162 ₹
Chg in FII Hold 0.01 % Chg in DII Hold 0.02 % PAT Qtr 372 Cr. PAT Prev Qtr 63.2 Cr.
RSI 59.8 MACD 6.97 Volume 10,05,472 Avg Vol 1Wk 9,00,326
Low price 117 ₹ High price 215 ₹ PEG Ratio 0.28 Debt to equity 0.00
52w Index 44.6 % Qtr Profit Var 5.13 % EPS 7.11 ₹ Industry PE 31.7

📊 NIACL presents moderate fundamentals. ROE (3.54%) and ROCE (3.72%) remain weak, reflecting limited efficiency. EPS of 7.11 ₹ supports profitability, but margins are thin. The company is debt-free (Debt-to-equity 0.00), which adds financial stability. Dividend yield of 1.12% provides steady income. Valuation appears reasonable with P/E at 22.6, below industry average (31.7), and PEG ratio of 0.28 suggesting undervaluation relative to growth. Quarterly PAT surged (372 Cr. vs 63.2 Cr.), highlighting earnings recovery. However, long-term growth visibility remains modest.

💡 Entry Price Zone: Ideal accumulation range is between 145 ₹ – 155 ₹, near 50 DMA (150 ₹) and below 200 DMA (162 ₹). Buying closer to 160 ₹ is acceptable for long-term investors but may limit upside.

📈 Long-Term Holding Guidance: NIACL is suitable for conservative investors seeking stability and modest returns. Long-term holding (18–24 months) is justified if profitability sustains and ROE improves. Partial exits can be considered near 200–210 ₹ if earnings momentum slows.

Positive

  • Debt-free structure ensures financial stability.
  • Dividend yield (1.12%) provides steady income.
  • PEG ratio (0.28) indicates undervaluation relative to growth.
  • Quarterly PAT surged significantly (372 Cr. vs 63.2 Cr.).
  • Technical indicators (RSI 59.8, MACD 6.97) show near-term strength.

Limitation

  • Low ROE (3.54%) and ROCE (3.72%) reflect weak efficiency.
  • Stock trades with limited growth visibility.
  • High volatility with 52-week range (117 ₹ – 215 ₹).

Company Negative News

  • Institutional confidence remains weak with minimal FII (+0.01%) and DII (+0.02%) changes.
  • Profitability metrics remain below industry averages.

Company Positive News

  • Quarterly PAT surged, showing strong recovery momentum.
  • Technical indicators suggest near-term bullishness.

Industry

  • Industry PE at 31.7, higher than NIACL’s 22.6, indicating relative undervaluation.
  • Insurance sector remains resilient with steady demand and regulatory support.

Conclusion

✅ NIACL is a moderately attractive candidate for long-term investment, supported by undervaluation, dividend yield, and recent earnings recovery. However, low ROE and ROCE limit its growth potential. Best suited for conservative investors seeking stability and modest returns. Accumulate near support levels and hold for 18–24 months, with partial exits on rallies near 200 ₹.

Would you like me to extend this with a peer valuation overlay (e.g., GIC, ICICI Lombard, SBI Life) so you can see how NIACL compares across the insurance sector?

NIFTY 50 - Fundamental Stock Watchlist

NEXT 50 - Fundamental Stock Watchlist

MIDCAP - Fundamental Stock Watchlist

SMALLCAP - Fundamental Stock Watchlist